News Daily News Testosterone Doesn’t Cause CV Events in High-Risk Men With Hypogonadism Caitlin E. Cox June 16, 2023
News Daily News Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2 Michael O'Riordan June 14, 2023
News Daily News Patients Most Vulnerable to CVD the Least Likely Use Wearable Devices Caitlin E. Cox June 13, 2023
News Daily News Migraine With Aura Doesn’t Hone CV Risk Prediction in Middle-aged Women Caitlin E. Cox June 08, 2023
News Conference News EAS 2023 With New LDL Goalposts in FH, Combo Therapy Must Start Early Michael O'Riordan May 29, 2023
News Conference News SCAI 2023 CLIPPER Attempts to Draw Out Useful Quality Metrics for CLTI L.A. McKeown May 25, 2023
News Conference News SCAI 2023 Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI L.A. McKeown May 24, 2023
News Conference News EAS 2023 Variable Response to Novel PCSK9 Inhibitor Lerodalcibep in LIBERATE-HoFH Michael O'Riordan May 24, 2023
News Features Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar L.A. McKeown May 12, 2023
News Daily News Think Differently: Diabetes, CVD Risks in Asian Americans Not Uniform, AHA Says Caitlin E. Cox May 09, 2023
News Daily News Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA Michael O'Riordan May 03, 2023
News Daily News Sugary Drinks Up CVD and All-Cause Mortality Risks in Type 2 Diabetes Michael O'Riordan May 01, 2023
News Daily News Breast Cancer Deaths Lower With Statin Therapy, Taiwanese Data Hint Caitlin E. Cox April 26, 2023
News Daily News AI Gleans Insights Into Statin Questions, Misinformation Online L.A. McKeown April 26, 2023
News Daily News New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF L.A. McKeown April 19, 2023
News Daily News CV Risk Disparities by Race/Ethnicity Persist in Childhood Cancer Survivors Yael L. Maxwell April 13, 2023
News Daily News REPRIEVE Stopped: Big MACE Reductions With Statins in HIV+ Subjects Shelley Wood April 12, 2023